VNDA - Vanda stock jumps as FDA approves Fanapt tablets for bipolar disorder
2024-04-03 06:22:57 ET
Vanda Pharmaceuticals ( NASDAQ: VNDA ) shares jumped 29% premarket on Wednesday after the U.S. Food and Drug Administration (FDA) cleared its Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults....
Vanda stock jumps as FDA approves Fanapt tablets for bipolar disorder